Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jul 2014

Kuhn Elisabetta, Bahadirli-Talbott Asli, Shih Ie-Ming

Abstract excerpt

Uterine serous carcinoma accounts for only 10% of all uterine epithelial cancers, but is the leading cause of death among them. The pathogenesis of this aggressive neoplasm has been largely elusive until recently, when comprehensive genome-wide analyses of uterine serous carcinoma have been performed. Among amplified cancer-related genes, CCNE1, encoding for cyclin E1, is frequently amplified in uterine serous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin E
Share to Cystadenocarcinoma, Serous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Gene Amplification

Share to Gene Dosage

Share to In Situ Hybridization, Fluorescence

Share to Oncogene Proteins

Share to Uterine Neoplasms

Source

Identifiers

PMID: 24309323
DOI: 10.1038/modpathol.2013.209

Genes

CCNE1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma.PMID 24309323Read ↗

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.Semantic proximity Read ↗

A multiomics comparison between endometrial cancer and serous ovarian cancerSemantic proximity Read ↗

Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo.Semantic proximity Read ↗

Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.Semantic proximity Read ↗

Amplicon profiles in ovarian serous carcinomas.Semantic proximity Read ↗

CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinomaSemantic proximity Read ↗

Gene amplification <i>CCNE1</i> is related to poor survival and potential therapeutic target in ovarian cancerSemantic proximity Read ↗

Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer.Semantic proximity Read ↗

Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas.Semantic proximity Read ↗

Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.Semantic proximity Read ↗

Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical OutcomeSemantic proximity Read ↗

KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.